Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

The Legitimacy of Healthcare and Public HealthCovid-19 Pandemic, Hydroxychloroquine, and Healthcare System in Turkey

The Legitimacy of Healthcare and Public Health: Covid-19 Pandemic, Hydroxychloroquine, and... [During the Covid-19 pandemic, certain drugs were touted as ‘miracle cures’. One was hydroxychloroquine (HCQ), an anti-malarial drug, which was used for the Covid-19 treatment, despite a lack of evidence for its efficacy and side effects. After WHO stopped recommending HCQ for the treatment of Covid-19 in July 2020, Turkey insisted on using the drug. This article investigates to what extent health policies that are imposed in the name of the common good are received as il/legitimate at the grassroots. How is HCQ treatment received at the grassroots? What tensions exist, if any, between the government health policies and the public response regarding this treatment? How do the patients and doctors react to the use of HCQ in the treatment of Covid-19? What does the administration of a non-evidence-based drug disclose about the healthcare system in Turkey? This chapter draws on ethnographic evidence collected among medical doctors and patients and on media research on the Turkish government’s recognition of the Covid-19 cases in March 2020 and its decision to stop the use of HCQ in May 2021.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

The Legitimacy of Healthcare and Public HealthCovid-19 Pandemic, Hydroxychloroquine, and Healthcare System in Turkey

Editors: Pardo, Italo; Prato, Giuliana B.

Loading next page...
 
/lp/springer-journals/the-legitimacy-of-healthcare-and-public-health-covid-19-pandemic-xxj2uWGwAI

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
ISBN
978-3-031-25591-5
Pages
113 –129
DOI
10.1007/978-3-031-25592-2_6
Publisher site
See Chapter on Publisher Site

Abstract

[During the Covid-19 pandemic, certain drugs were touted as ‘miracle cures’. One was hydroxychloroquine (HCQ), an anti-malarial drug, which was used for the Covid-19 treatment, despite a lack of evidence for its efficacy and side effects. After WHO stopped recommending HCQ for the treatment of Covid-19 in July 2020, Turkey insisted on using the drug. This article investigates to what extent health policies that are imposed in the name of the common good are received as il/legitimate at the grassroots. How is HCQ treatment received at the grassroots? What tensions exist, if any, between the government health policies and the public response regarding this treatment? How do the patients and doctors react to the use of HCQ in the treatment of Covid-19? What does the administration of a non-evidence-based drug disclose about the healthcare system in Turkey? This chapter draws on ethnographic evidence collected among medical doctors and patients and on media research on the Turkish government’s recognition of the Covid-19 cases in March 2020 and its decision to stop the use of HCQ in May 2021.]

Published: May 4, 2023

Keywords: Turkey; Healthcare system; Covid-19 pandemic; Hydroxychloroquine

There are no references for this article.